Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 640 of 5804
-
New combo treatment shows promise for inoperable liver cancer
Disease control CompletedPatients with unresectable hepatocellular carcinoma will receive hepatic arterial infusion chemotherapy (HAIC) sequential transarterial embolization combined with lenvatinib and tislelizumab.
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Experimental eye injection aims to restore sight in rare blindness conditions
Disease control CompletedA phase I/II dose-escalating study of the safety, tolerability and efficacy of KIO-301 administered intravitreally to patients with retinitis pigmentosa and choroideremia (ABACUS).
Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New shot could ease swallowing trouble for thousands
Disease control OngoingA randomized, double-blind, placebo-controlled multicenter, phase 3 study to evaluate the efficacy and safety of tezepelumab administered subcutaneously (SC) using an accessorized pre-filled syringe (APFS) versus placebo in adult and adolescent patients with eosinophilic esophagi…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill aims to slow muscle damage in becker MD
Disease control OngoingA study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON study was expanded to include an additional 120 adult participants in a cohort called GRAND CANYON, that is a multicenter, randomize…
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New vaccine aims to train immune system against lynch syndrome cancers
⭐️ VACCINE ⭐️ OngoingThis phase Ib/II trial evaluates the safety and effect of the Nous-209 vaccine in Lynch syndrome patients. Lynch syndrome is an inherited disorder in which affected individuals have a higher-than-normal chance of developing colorectal cancer and certain other types of cancer, oft…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC
-
Brain tumor drug repurposed: new combo therapy targets recurrent glioblastoma
Disease control Recruiting nowThe investigational drug 5-ALA (known under the trade name Gliolan®) is an approved drug for the surgical removal of malignant glioma (WHO grade III and IV). In this trial, the drug is being tested outside of its actual approval as a radiosensitizer in combination with convention…
Phase: PHASE1, PHASE2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a psoriasis drug help save Insulin-Making cells in type 1 diabetes?
Disease control OngoingAlthough the clinical onset of type 1 diabetes (T1D) is acute, the progression of T1D occurs over many years often in a patchy manner with inflammation in certain lobes of the pancreas, leaving other lobes unaffected and long-lasting beta cells remain functional decades after dia…
Phase: PHASE2 • Sponsor: Göteborg University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Exercise may boost Chemo's power against breast cancer
Disease control Recruiting nowNeoadjuvant chemotherapy (NACT) is increasingly used in breast cancer. The best proof of NACT efficacy is pathological complete response (pCR), i.e. the absence of invasive tumour on post-NACT surgical histopathology. While it is known that physical exercise can help patients to …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Lung transplant patients may get better flu protection with high-dose vaccine
Disease control Recruiting nowLung allograft recipients have a higher burden of influenza disease and greater associated morbidity and mortality compared with healthy controls. Induction and early maintenance immunosuppression is thought to impair immunogenicity to standard dose inactivated influenza vaccine.…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for Hard-to-Treat lymphoma: experimental drug shows promise
Disease control OngoingPurinostat mesylate for injection (PM) was the novel and highly potent Class Ia and IIb HDAC selective inhibitor. The results of regular blood sampling analysis of the mouse B-cell lymphoma model induced by ighmyc transgenic mice showed that the treatment of PM in each group redu…
Phase: PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New triple therapy shows promise for cystic fibrosis in Long-Term trial
Disease control OngoingThe purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New cocktail of drugs shows promise for tough lung cancer
Disease control OngoingThis is a multicenter, open-label, non-randomized, single arm, 2 parts, phase II clinical trial evaluating the efficacy and safety of pembrolizumab and lenvatinib plus standard of care chemotherapy (with carboplatin and etoposide ) in subjects with histologically confirmed extens…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New pill may help anemia patients avoid frequent blood transfusions
Disease control OngoingThis purpose of this study is to establish proof of concept of tebapivat in participants with LR-MDS in Phase 2a and to evaluate the effect of tebapivat on transfusion independence (TI) in participants with LR-MDS in phase 2b.
Phase: PHASE2 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Steroid shots may tame cluster headaches for months
Disease control Recruiting nowBackground: \- The effect of repeated GON-injections has never been studied in a double-blind randomized trial as a prophylactic therapy in a well-documented group of chronic patients. As such, (repeated) GON-injection has not yet found its place in current (inter)national treat…
Phase: PHASE3 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New cocktail of four drugs aims to tackle childhood cancers that Won't go away
Disease control Recruiting nowThis is a phase I/II study to evaluate the safety of combining intravenous (IV) atezolizumab and bevacizumab every three weeks, with daily oral cyclophosphamide and pharmacokinetic (PK)-guided sorafenib in children and adolescent and young adults (AYA) with relapsed or refractory…
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New vaccine shows promise in protecting older adults from pneumococcal disease
Prevention CompletedThis is a phase 3, randomized, double-blind, active comparator-controlled study of the safety, tolerability, and immunogenicity of V116 in pneumococcal vaccine-naïve adults 50 years of age and older. The polyvalent (23-valent) pneumococcal vaccine, PPSV23, is the active comparato…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New mRNA vaccine aims to shield teens and young adults from common virus
⭐️ VACCINE ⭐️ CompletedThe main purpose of study is to evaluate the safety and immunogenicity of different dose levels of mRNA-1647 versus control in healthy cytomegalovirus (CMV)-seronegative and CMV-seropositive female and male participants 9 to 15 years of age. In addition, mRNA-1647 will be evaluat…
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:02 UTC
-
Eye injection could save sight in kids with retinoblastoma
Disease control Recruiting nowThis phase II trial tests the safety and side effects of adding melphalan (by injecting it into the eye) to standard chemotherapy in early treatment of patients with retinoblastoma (RB). RB is a type of cancer that forms in the tissues of the retina (the light-sensitive layers of…
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis is a single-arm, observational registry study determining the effects of reduced radiation dose in select patients with human papillomavirus (HPV) positive oropharyngeal cancer.
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New stem cell transplant method shows promise for kids with tough blood cancers
Disease control Recruiting nowThis single arm pilot phase I study with safety run-in is designed to estimate the safety and efficacy of a familial mismatched or haploidentical hematopoietic stem cell transplantation (haplo-HSCT) using a novel graft modification technique (selective αβ-TCR and CD19 depletion).…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC